| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Mar―25 |
The Economic Value of Non-pharmaceutical Interventions for Influenza and COVID-19: A Systematic Review |
Hui Yee Yeo, Trinh Manh Hung, Nhung Nghiem, Steffen Albrecht, Nikki Turner, Peter McIntyre |
| 2 |
[GO] |
2025―Jan―20 |
Productivity Losses due to Health Problems Arising from COVID-19 Pandemic: A Systematic Review of Population-Level Studies Worldwide |
Paweł Niewiadomski, Marta Ortega-Ortega, Błażej Łyszczarz |
| 3 |
[GO] |
2024―Apr―19 |
Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China |
Ningxin Ding, Huixuan Zhou, Chen Chen, Hui Chen, Yunfeng Shi |
| 4 |
[GO] |
2024―Apr―10 |
Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis |
Enxue Chang, Haofei Li, Wanji Zheng, Lan Zhou, Yanni Jia, Wen Gu, et al. (+8) Yiyin Cao, Xiaoying Zhu, Juan Xu, Bo Liu, Mao You, Kejun Liu, Mingsi Wang, Weidong Huang |
| 5 |
[GO] |
2023―Nov―01 |
Cost-Effectiveness of the Second COVID-19 Booster Vaccination in the USA |
Rui Li, Pengyi Lu, Christopher K. Fairley, José A. Pagán, Wenyi Hu, Qianqian Yang, et al. (+4) Guihua Zhuang, Mingwang Shen, Yan Li, Lei Zhang |
| 6 |
[GO] |
2023―May―27 |
Symptomatic SARS-CoV-2 Episodes and Health-Related Quality of Life |
Caterina Alacevich, Inna Thalmann, Catia Nicodemo, Simon de Lusignan, Stavros Petrou |
| 7 |
[GO] |
2023―May―08 |
Public Preferences for Introducing a COVID-19 Certificate: A Discrete Choice Experiment in the Netherlands |
J. Veldwijk, J. van Exel, E. W. de Bekker-Grob, N. Mouter |
| 8 |
[GO] |
2023―Mar―16 |
Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand |
Waranya Rattanavipapong, Chittawan Poonsiri, Wanrudee Isaranuwatchai, Sopon Iamsirithaworn, Jutarat Apakupakul, Chaninan Sonthichai, et al. (+2) Rungrueng Kitphati, Yot Teerawattananon |
| 9 |
[GO] |
2022―Sep―14 |
Determinants of COVID-19 Vaccine Rollouts and Their Effects on Health Outcomes |
Pragyan Deb, Davide Furceri, Daniel Jimenez, Siddharth Kothari, Jonathan D. Ostry, Nour Tawk |
| 10 |
[GO] |
2022―Aug―02 |
An Economic Evaluation of Government-Funded COVID-19 Testing in Australia |
Jonathan Karnon, Hossein Haji Ali Afzali, Billie Bonevski |
| 11 |
[GO] |
2022―Jan―10 |
Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China |
Jianhong Xiao, Yihui Wu, Min Wang, Zegang Ma |
| 12 |
[GO] |
2021―Dec―10 |
The Effects of School Closures on COVID-19: A Cross-Country Panel Analysis |
Vincenzo Alfano |
| 13 |
[GO] |
2021―Nov―29 |
Is There Broad-Based Support in High-Income Countries for COVID-19 Vaccine Donation? Evidence from Seven Countries |
Laurence S. J. Roope, Adrian Barnett, Paolo Candio, Mara Violato, Raymond Duch, Philip M. Clarke |
| 14 |
[GO] |
2021―Nov―01 |
Financial Incentives in the Path to Recovery from the COVID-19 Pandemic |
Afschin Gandjour |
| 15 |
[GO] |
2021―Oct―05 |
COVID-19 Vaccine Demand and Financial Incentives |
Carlos E. Carpio, Ioana A. Coman, Oscar Sarasty, Manuel García |
| 16 |
[GO] |
2021―Jul―27 |
How Much Money Should be Paid for a Patient to Isolate During the COVID-19 Outbreak? A Discrete Choice Experiment in Iran |
Enayatollah Homaie Rad, Mohammad Hajizadeh, Vahid Yazdi-Feyzabadi, Sajad Delavari, Zahra Mohtasham-Amiri |
| 17 |
[GO] |
2021―Jul―08 |
Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines |
Chris Painter, Wanrudee Isaranuwatchai, Juthamas Prawjaeng, Hwee Lin Wee, Brandon Wen Bing Chua, Vinh Anh Huynh, et al. (+7) Jing Lou, Fang Ting Goh, Nantasit Luangasanatip, Wirichada Pan-Ngum, Wang Yi, Hannah Clapham, Yot Teerawattananon |
| 18 |
[GO] |
2021―Jun―25 |
Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines |
Christian Alvin H. Buhat, Destiny S. M. Lutero, Yancee H. Olave, Kemuel M. Quindala, Mary Grace P. Recreo, Dylan Antonio S. J. Talabis, et al. (+3) Monica C. Torres, Jerrold M. Tubay, Jomar F. Rabajante |
| 19 |
[GO] |
2021―May―11 |
Comment on: “Willingness to Pay for a COVID-19 Vaccine” |
Philipp Sprengholz, Cornelia Betsch |
| 20 |
[GO] |
2021―May―11 |
Authors’ Reply to Sprengholz and Betsch: “Willingness to Pay for a COVID-19 Vaccine” |
Leidy Y. García, Arcadio A. Cerda |
| 21 |
[GO] |
2021―Feb―23 |
Willingness to Pay for a COVID-19 Vaccine |
Arcadio A. Cerda, Leidy Y. García |
| 22 |
[GO] |
2021―Jan―20 |
The Vatican City State Internal Healthcare System Response to COVID-19 Pandemic: Prevention and Control Strategies |
Andrea Arcangeli, Massimo Ralli, Fabio De-Giorgio, Paolo Maurizio Soave, Lucia Ercoli |
| 23 |
[GO] |
2021―Jan―13 |
How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in Germany |
Afschin Gandjour |
| 24 |
[GO] |
2020―Aug―24 |
Comment on: “The Italian NHS: What Lessons to Draw from COVID-19?” |
Davide Golinelli, Andrea Bucci, Kadjo Yves Cedric Adja, Fabrizio Toscano |
| 25 |
[GO] |
2020―Jun―03 |
The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis |
Vincenzo Alfano, Salvatore Ercolano |
| 26 |
[GO] |
2020―May―26 |
The Italian NHS: What Lessons to Draw from COVID-19? |
Livio Garattini, Michele Zanetti, Nicholas Freemantle |
| 27 |
[GO] |
2020―May―21 |
Using Insights from Behavioral Economics to Mitigate the Spread of COVID-19 |
Moslem Soofi, Farid Najafi, Behzad Karami-Matin |
| 28 |
[GO] |
2020―May―07 |
Impact of a Global Pandemic on Health Technology Assessment |
Paula K. Lorgelly, Amanda Adler |
| 29 |
[GO] |
2020―Apr―16 |
The Case for a Temporary COVID-19 Income Tax Levy Now, During the Crisis |
Jonathan Karnon |
| 30 |
[GO] |
2020―Apr―08 |
Why Only Test Symptomatic Patients? Consider Random Screening for COVID-19 |
William V. Padula |
| 31 |
[GO] |
2020―Apr―05 |
A Simple Decision Analysis of a Mandatory Lockdown Response to the COVID-19 Pandemic |
Jonathan Karnon |
| 32 |
[GO] |
2020―Apr―05 |
COVID-19 Pandemic, a War to be Won: Understanding its Economic Implications for Africa |
John E. Ataguba |
